There is limited data on direct interactions between daptomycin and cancer treatments such as chemotherapy drugs. However, it is essential to monitor patients closely for potential side effects, as both daptomycin and chemotherapy agents can have nephrotoxic and myotoxic effects. Coordination between oncologists and infectious disease specialists is crucial to ensure optimal patient outcomes.
